BioLineRx Ltd. Increase Decrease In Fair Value Measurement Liabilities
BioLineRx Ltd. (BLRX) reported Increase Decrease In Fair Value Measurement Liabilities of $8.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities · last filed 2026-03-23
| Period end | Increase Decrease In Fair Value Measurement Liabilities 12 month |
|---|---|
| 2025-12-31 | $8.60M 20-F · filed 2026-03-23 |
| 2024-12-31 | $18.96M 20-F · filed 2026-03-23 |
| 2023-12-31 | -$11.05M 20-F · filed 2026-03-23 |
| 2022-12-31 | $6.42M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$1.94M 20-F · filed 2024-03-26 |
| 2020-12-31 | -$5.14M 20-F · filed 2023-03-22 |
| 2019-12-31 | $4.63M 20-F · filed 2022-03-16 |
| 2018-12-31 | $1.74M 20-F · filed 2021-02-23 |
| 2017-12-31 | -$127.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | $207.00K 20-F · filed 2019-03-28 |
| 2015-12-31 | $1.29M 20-F · filed 2018-03-06 |